.Pharmacolibrary.Drugs.D_Dermatologicals.D07A_CorticosteroidsPlain.D07AA02_Hydrocortisone.Hydrocortisone .Pharmacolibrary.Drugs.D_Dermatologicals.D07A_CorticosteroidsPlain.D07AA02_Hydrocortisone.Hydrocortisone| name: | Hydrocortisone |
| ATC code: | D07AA02 | route: | intravenous |
| n-compartments | 2 |
Hydrocortisone is a synthetic form of cortisol, a glucocorticoid hormone produced by the adrenal cortex. It is primarily used as an anti-inflammatory and immunosuppressive agent in various conditions such as adrenal insufficiency, allergic reactions, autoimmune disorders, and skin diseases. Hydrocortisone is approved and widely used both systemically and topically in clinical practice.
Pharmacokinetic parameters reported in healthy adult volunteers after intravenous administration.
Hamitouche, N, et al., & Laviolle, B (2017). Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers. The AAPS journal 19(3) 727–735. DOI:10.1208/s12248-016-0041-9 PUBMED:https://pubmed.ncbi.nlm.nih.gov/28083797
Vincze, I, et al., & Kopitkó, C (2022). Assessment of Antibiotic Pharmacokinetics, Molecular Biomarkers and Clinical Status in Critically Ill Adults Diagnosed with Community-Acquired Pneumonia and Receiving Intravenous Piperacillin/Tazobactam and Hydrocortisone over the First Five Days of Intensive Care: An Observational Study (STROBE Compliant). Journal of clinical medicine 11(14) –. DOI:10.3390/jcm11144140 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35887904
Knych, HK, et al., & Kass, PH (2019). Pharmacokinetics of intravenous flumetasone and effects on plasma hydrocortisone concentrations and inflammatory mediators in the horse. Equine veterinary journal 51(2) 238–245. DOI:10.1111/evj.13002 PUBMED:https://pubmed.ncbi.nlm.nih.gov/30080272